University of Sheffield have announced ground breaking research  into the prevention of secondary breast cancer. The research in partnership with the University of Copenhagen has found that high levels of  a particular enzyme is what leaves to secondary or metastatic breast cancer. The pioneering research, co-led by Dr Alison Gartland at the University of Sheffield’s Department of Human Metabolism, could lead to a better prognosis for cancer patients in the longer term.